Does Vitamin B12 Cognition Randomized Trial work?

Updated June 2026

Quick Answer

Vitamin B12 Cognition Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Background/objectives Evidence linking vitamins D and B 12 to psychiatric outcomes remains heterogeneous across designs, populations, phenotypes, exposures, and outcome formats.

Key Takeaways

  • 01Background/objectives Evidence linking vitamins D and B 12 to psychiatric outcomes remains heterogeneous across designs, populations, phenotypes, exposures, and outcome formats. [Moroianu LA (2026)]
  • 02Methods We conducted a PRISMA 2020 systematic review and exploratory meta-analysis of nutrient-specific status and supplementation evidence. [Moroianu LA (2026)]
  • 03Effects were harmonized to odds ratios (ORs) for cross-family comparability and pooled using Hartung-Knapp random-effects models; supplementation evidence was additionally interpreted on the standardized mean difference (SMD) scale. [Moroianu LA (2026)]
  • 04There is also the assumption that a water-soluble vitamin carries negligible risk [,]. [Yepes-Calderón Manuela (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin B12 Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background/objectives Evidence linking vitamins D and B 12 to psychiatric outcomes remains heterogeneous across designs, populations, phenotypes, exposures, and outcome formats. [Moroianu LA (2026); evidence level 1] - Methods We conducted a PRISMA 2020 systematic review and exploratory meta-analysis of nutrient-specific status and supplementation evidence. [Moroianu LA (2026); evidence level 1] - Effects were harmonized to odds ratios (ORs) for cross-family comparability and pooled using Hartung-Knapp random-effects models; supplementation evidence was additionally interpreted on the standardized mean difference (SMD) scale. [Moroianu LA (2026); evidence level 1] - There is also the assumption that a water-soluble vitamin carries negligible risk [,]. [Yepes-Calderón Manuela (2026); evidence level 3] - A critical appraisal is warranted to delineate evidence-based indications, clarify benefits and harms in replete populations, and guide prudent dosing and monitoring. [Yepes-Calderón Manuela (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Vitamin D and Vitamin B<sub>12</sub> in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence.
  2. Vitamin B 12 Supplementation: Is More Always Better?